Literature DB >> 4622188

C3b inactivator of man. 3. Further purification and production of antibody to C3b INA.

S Ruddy, L G Hunsicker, K F Austen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4622188

Source DB:  PubMed          Journal:  J Immunol        ISSN： 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  11 in total

1.  The alternate pathway of complement activation. The role of C3 and its inactivator (KAF).

Authors:  P A Nicol; P J Lachmann
Journal:  Immunology       Date:  1973-02       Impact factor: 7.397

2.  Binding of soluble immune complexes to Raji lymphocytes. Role of receptors for complement components, C1q and C3-C3b.

Authors:  R C Gupta; F C McDuffie; G Tappeiner; R E Jordon
Journal:  Immunology       Date:  1978-04       Impact factor: 7.397

3.  C3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase.

Authors:  K Whaley; P H Schur; S Ruddy
Journal:  J Clin Invest       Date:  1976-06       Impact factor: 14.808

4.  Isolation of circulating immune complexes by conglutinin and separation of antigen from dissociated complexes by immobilized protein A.

Authors:  R C Gupta; E M Tan
Journal:  Clin Exp Immunol       Date:  1981-10       Impact factor: 4.330

5.  Formation in the presence of C3 nephritic factor (C3NeF) of an alternative pathway C3 convertase containing uncleaved B.

Authors:  M R Daha; D T Fearon; K F Austen
Journal:  Immunology       Date:  1976-11       Impact factor: 7.397

6.  A low molecular weight inhibitor of the alternative complement pathway. I. Its isolation from human urine and the reaction mechanism.

Authors:  K Nagaki; M Matsumoto; H Kitamura
Journal:  Immunology       Date:  1980-12       Impact factor: 7.397

7.  Specificity of human lymphocyte complement receptors.

Authors:  G D Ross; M J Polley
Journal:  J Exp Med       Date:  1975-05-01       Impact factor: 14.307

8.  Modulation of the alternative complement pathways by beta 1 H globulin.

Authors:  K Whaley; S Ruddy
Journal:  J Exp Med       Date:  1976-11-02       Impact factor: 14.307

9.  Properdin factor D: characterization of its active site and isolation of the precursor form.

Authors:  D T Fearon; K F Austen; S Ruddy
Journal:  J Exp Med       Date:  1974-02-01       Impact factor: 14.307

10.  Two different complement receptors on human lymphocytes. One specific for C3b and one specific for C3b inactivator-cleaved C3b.

Authors:  G D Ross; M J Polley; E M Rabellino; H M Grey
Journal:  J Exp Med       Date:  1973-10-01       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.